PMID: 6985381Jan 1, 1982Paper

Utility of monoclonal antibodies in the immunologic phenotyping of acute lymphoblastic leukemia

Hybridoma
A L YuR E Sobol

Abstract

Peripheral blood and/or bone marrow lymphoblasts from 34 children and 11 adults with acute lymphoblastic leukemia (ALL) were evaluated with a monoclonal anti-Ia antibody and a monoclonal anti-pan T-cell antibody (T101) specific for a 65,000-dalton T-cell antigen (T65). Seventy-six per cent of cases were Ia+T65-, 20% were Ia-T65+ and the remaining 4% were Ia-T65-. Anti-Ia and T101 reactivity were mutually exclusive and no Ia+T65+ cases were identified. In childhood ALL, the Ia+T65- phenotype was associated with good prognostic factors and longer median disease-free survival than Ia-T65+ patients whose clinical parameters resembled those characteristic of high-risk T-cell ALL. Included in the Ia-T65+ group were three E-rosette negative cases with clinical features of T-cell disease. Our findings compare favorably with the results of other investigators utilizing polyclonal antisera and suggest that these monoclonal antibodies, which offer the advantages of monospecific standardized reagents, will prove useful in the immunologic characterization of ALL.

References

Jan 29, 1976·The New England Journal of Medicine·I TsukimotoB C Lampkin
Jun 1, 1978·Journal of the National Cancer Institute·J MinowadaE Tatsumi
Apr 20, 1978·The New England Journal of Medicine·L B VoglerM D Cooper
Oct 27, 1978·Biochimica Et Biophysica Acta·M Greaves, G Janossy
Mar 1, 1979·European Journal of Immunology·A J McMichaelC Milstein
Apr 17, 1975·The New England Journal of Medicine·L Sen, L Borella
Mar 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·E L ReinherzS F Schlossman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.